Cartesian Therapeutics, Inc. — Director's Dealing 2016

Jun 22, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21

Reporting Person: VTB Capital I2BF Netherlands, B.V. (10% Owner)
Reporting Person: Selecta RKFN, Ltd. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series SRN Convertible Preferred Stock	$		Common Stock (178890)		Indirect
Series SRN Convertible Preferred Stock	$		Common Stock (178890)		Indirect

Footnotes

F1: The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.